Abstract β-Adrenergic receptor blockers (β-blockers) are well-known useful and cost-
effective drugs for managing hypertensive patients with coronary heart disease, stroke, and …

Systemic arterial hypertension (SAH) is a chronic disease of multifactorial origin and one of
the main risk factors for major adverse cardiovascular events (MACE), which are the leading …

Nebivolol (NEB) is widely used for the treatment of hypertension and chronic heart failure
and has become an ubiquitous emerging organic pollutant. It has been shown to undergo …

Abstract Nebivolol (NEB), a β-blocker frequently used to treat cardiovascular diseases, has
been widely detected in aquatic environments, and can be degraded under exposure to UV …

The aim was to evaluate the effects and mechanisms of nebivolol on renal damage in
Zucker diabetic fatty (ZDF) rats, in comparison with those of atenolol and captopril. Animals …

We studied whether the β 1-adrenergic antagonist nebivolol would prevent ethanol-induced
reactive oxygen species generation and lipoperoxidation in the rat renal cortex. Male Wistar …

This study aimed to investigate the potential of nebivolol in preventing doxorubicin-induced
cardiotoxicity by targeting the inflammatory, oxidative, and apoptotic pathways. Twenty-eight …

O tenofovir disoproxil fumarato (TDF), componente amplamente prescrito em regimes
antirretrovirais, tem sido associado à nefrotoxicidade. O nebivolol é um bloqueador seletivo …

Contrast-induced nephropathy (CIN) is the main cause of acute kidney injury and worsens
the prognosis of chronic kidney disease. To evaluate the clinical risk score of CIN …

The blood pressure (BP) targets for patients with chronic kidney disease (CKD) to decrease
the risk of cardiovascular outcomes and progression of renal disease remain unclear. In …